Form 6-K AEGON LTD. For: Apr 15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2026
Commission File Number: 001-10882
Aegon Ltd
(Translation of registrant's name into English)
| Aegon Limited An exempted company with liability limited by shares www.aegon.com | Statutory seat Canon’s Court 22 Victoria Street Hamilton HM 12 Bermuda | Principle place of business World Trade Center Schiphol Boulevard 223 1118 BH Schiphol The Netherlands | Bermuda Registrar of Companies number: 202302830 (September 30, 2023) Dutch Chamber of Commerce number: 27076669 Aegon Limited is a non-resident company under the Dutch Act Non Residential Companies |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Aegon Ltd | ||
| (Registrant) | ||
| Date: April 15, 2026 | /s/ J.O. van Klinken | |
| J.O. van Klinken | ||
| Executive Vice President and General Counsel | ||
Aegon to sell Aegon UK to Standard Life for a total consideration of GBP 2.0 billion
Schiphol, April 15, 2026
- Transaction marks the completion of the strategic review of Aegon UK, further supporting Aegon in its ambition to become a leading US life insurance and retirement group
- The proceeds are valued at GBP 2.0 billion and consist of a shareholding of 15.3% (181.1 million shares) in Standard Life plc (Standard Life)1 and a cash amount of GBP 0.75 billion. Any remittances taken out of Aegon UK between the signing and closing of the transaction will be deducted from the GBP 0.75 billion cash amount
- Total consideration equivalent to 14.2x 2025 operating result after tax and 1.9x 2025 IFRS Shareholder’s equity2
- The cash received from the transaction, minus the value of the remittances that were expected to be received from Aegon UK between the signing and the closing of the transaction, is expected to be used for a combination of deleveraging and share buybacks, once the transaction is completed
- Aegon’s group financial ambitions for 2026 and 2027, as communicated at its Capital Markets Day 2025, will be updated to reflect the transaction announced today, with target growth rates unchanged but starting from an adjusted base level
- Aegon’s asset management activities in the UK will remain part of Aegon’s global asset manager and will be an important asset management partner for the new combined business
- The transaction is expected to close around the end of 2026, subject to customary conditions, including regulatory approvals
- The relationship agreement with Standard Life entitles Aegon to appoint one non-Executive Director on the Board of Standard Life.
Lard Friese, Aegon CEO, commented: “The transaction represents an important step in our ambition to become a leading US life insurance and retirement group. The terms reflect our commitment to creating value for shareholders, and through our shareholding we will benefit from further value creation in the combined business. Standard Life is the right owner for Aegon UK and a good home for our employees: we share the same values and a strong commitment to customers, and together the businesses will create the UK’s largest retirement savings and income provider. Aegon’s asset management business in the UK will remain an important asset management partner to the new combined business.”
Andy Briggs, Standard Life CEO, said: “With financial wellbeing at the heart of everything it does, Aegon UK’s values and culture are aligned with our own. Together, we will not only be stronger, we will be better - helping our customers achieve better outcomes and greater financial security in later life. I look forward to welcoming everyone in Aegon UK to Standard Life in due course and working together to capture the huge potential in front of us.”
Use
of proceeds and financial implications
The cash received from the transaction, minus
the value of remittances that were expected to be received from Aegon UK between the signing
and the closing of the transaction, is expected to be used for a combination of deleveraging
and share buy-backs, once the transaction is completed.
Following the completion of the transaction, Aegon’s group financial guidance for 2026 and 2027 will be updated to reflect the divestment of Aegon UK:
- The group operating result run-rate is expected to grow by around 5% per annum between 2025 and 2027, from a proforma 2025 run-rate of EUR 1.3 – 1.5 billion*
- OCG after holding funding and operating expenses is expected to grow between 0% and 5% per annum over the same timeframe, from a proforma 2025 run-rate of EUR 0.7-0.75 billion*
- Free cash flow run rate is expected to increase at around 5% per annum between 2025 and 2027. The free cash flow run-rate will be adjusted by removing the UK contribution (EUR 120 million in 2025 terms) from 2026 onwards and incorporating the free cash flow attributable to the equity stake received as part of the disposal structure post-closing
- Dividend per share is expected to grow in excess of 5% per annum, which remains unchanged from the CMD 2025 guidance
*The proforma 2025 run-rate figures reflect the run-rate communicated at the CMD 2025, updated to reflect the Aegon UK transaction announced today.
On a pro-forma 2025 basis, and prior to any deleveraging or share buyback initiatives, the transaction is expected to result in a 5%-point reduction in the Group Solvency ratio. At the same time, it is expected to have a positive impact of EUR 1.1 billion on Group shareholders’ equity and a negative impact of EUR 0.1 billion on Group Valuation Equity, as the loss of CSM exceeds the positive shareholders’ equity effect. The positive impact on the Group’s net result is expected to be EUR 0.6 billion.
As per Aegon’s accounting policies and until the completion of the transaction, Aegon UK will no longer contribute to the Group Operating result and Operating Capital Generation, and its IFRS result will be reported under “Other income/(charges)”.
The transaction is expected to close around the end of 2026, subject to customary conditions, including regulatory approvals. Following the completion of the transaction, Aegon will enter into a lock-up period with respect to the shares received as part of the transaction. This period will last until the earliest of 18 months following the transaction completion date or the completion of the redomiciliation of Aegon Ltd to the United States.
Contacts
| Media relations | Investor relations |
| Carolien van der Giessen | Yves Cormier |
| +31(0) 6 11953367 | +44 782 337 1511 |
| [email protected] | [email protected] |
About
Aegon
Aegon is an international financial services holding company. Aegon’s
ambition is to become a leading US life insurance and retirement group. Aegon’s portfolio
of businesses includes fully owned businesses in the United States and United Kingdom, and
a global asset manager. Aegon also creates value by combining its international expertise
with strong local partners via insurance joint ventures in Spain & Portugal, China, and
Brazil, and via asset management partnerships in France and China. In addition, Aegon owns
a Bermuda-based life insurer and generates value via a strategic shareholding in a market
leading Dutch insurance and pensions company.
Aegon’s purpose of helping people live their best lives runs through all its activities. As a leading global investor and employer, Aegon seeks to have a positive impact by addressing critical environmental and societal issues. Aegon is headquartered in Schiphol, the Netherlands, domiciled in Bermuda, and listed on Euronext Amsterdam and the New York Stock Exchange. More information can be found at aegon.com.
About
Standard Life
Standard Life is a retirement specialist focused entirely on retirement
saving and income. Standard Life is proud to manage around c£317bn in assets on behalf
of its 12 million customers, and champions the belief that everyone's journey to and through
retirement can be better. With its focus entirely on retirement savings and income Standard
Life wants to be the business that people trust to guide their retirement journey, helping
its customers achieve better outcomes and greater financial security in later life.
As a FTSE 100-listed group Standard Life is using its size, expertise and influence to shape the world Standard’s Life customers will retire into, and are committed to helping three million customers by 2035, take action towards a better retirement. Standard Life is a responsible investor with a clear commitment to supporting a more sustainable future. The company has achieved its net zero goal across its emissions for 2025 and is working towards net zero investment portfolios by 2050 or sooner. Standard Life is recognised as a leading employer, with long-standing accreditation as a Living Wage Employer, Living Pension Employer and Carer Positive Exemplary Employer and in 2025 became one of Britain’s Most Admired Companies in 2025.
Forward-looking
statements
The statements contained in this document that are not historical facts
are forward-looking statements as defined in the US Private Securities Litigation Reform
Act of 1995. The following are words that identify such forward-looking statements: aim,
believe, estimate, target, focus, intend, may, expect, anticipate, predict, project, counting
on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar
expressions as they relate to Aegon. These statements may contain information about financial
prospects, economic conditions and trends and involve risks and uncertainties. In addition,
any statements that refer to sustainability, environmental and social targets, commitments,
goals, efforts and expectations and other events or circumstances that are partially dependent
on future events are forward-looking statements. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are difficult to predict.
Aegon undertakes no obligation, and expressly disclaims any duty, to publicly update or revise
any forward-looking statements. Readers are cautioned not to place undue reliance on these
forward-looking statements, which merely reflect the company’s expectations at the
time of writing. Actual results may differ materially and adversely from expectations conveyed
in forward-looking statements due to changes caused by various risks and uncertainties. Such
risks and uncertainties include, but are not limited to, the following:
- Changes in general economic and/or governmental conditions, particularly in Bermuda, the United States, the United Kingdom and, in relation to Aegon’s shareholding in ASR Nederland N.V., and Aegon’s asset management business, the Netherlands.
- Civil unrest, (geo-) political tensions, military action or other instability in countries or geographic regions that affect our operations or that affect global markets.
- Changes
in the performance of financial markets, including emerging markets, such as:
- The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios.
- The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds.
- The effects of declining creditworthiness of certain public sector securities and the resulting decline in the value of government exposure that Aegon holds.
- The impact from volatility in credit, equity, and interest rates.
This document contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (596/2014). Further details of potential risks and uncertainties affecting Aegon are included in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the 2024 Integrated Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
1
Value of 15.3% stake is based on the closing price of Standard Life’s shares on Tuesday
April 14, 2026, and 181,080,690 shares to be received by Aegon upon closing of the transaction
as per the agreement.
2 Based on the following 2025 figures for Aegon UK:
operating result after tax of GBP 143 million and shareholders equity of GBP 1,077 million.
Attachment
- 20260415_PR_Aegon to sell Aegon UK to Standard Life for a total consideration of GBP 2.0 billion (https://ml-eu.globenewswire.com/Resource/Download/13cce271-3912-4859-8061-d7ae8614884d)
